Anika Therapeutics (ANIK) Tops Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $14.61 +2.89%
EPS Growth %: +115.4%
Financial Fact:
Provision for income taxes: 4.83M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +115.4%
Financial Fact:
Provision for income taxes: 4.83M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q2 EPS of ($0.12), $0.11 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $39.7 million versus the consensus estimate of $37.85 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
- Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
